Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Identify the best retirement plan tailored to your needs. Make informed decisions for a secure financial future.
20,379 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
NVIDIA just reported billion-dollar revenue, underscoring a surge in AI infrastructure spending. This article explain...
microsoft’s troubled problems just intensified as Microsoft restructures its AI operation amid mounting competitive p...
Oil markets bounce as Strait of Hormuz risks flare and Beijing delays a high-stakes summit. The United States undermi...
Meta Platforms paused the public rollout of its Avocado AI model to focus on quality, while expanding its Hyperion da...
Hess Midstream’s capital return program is under review as a $60 million buyback coincides with a high payout ratio a...
Rocket Lab is tightening revenue visibility with a growing backlog and stronger margins entering 2026. Analysts eye h...
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
Kevin O’Leary’s $4.2 billion Softkey exit in 1999 turned him into a millionaire, but the moment was surprisingly low-...
Bitcoin rose sharply after news that a five-day window for Iran talks could cool tensions, lifting broader markets. C...
Two major AI infrastructure players appear attractively priced as heavy investment in AI chips and automation presses...
Bitcoin hovers around $70,000 after a brief pullback, as volatility eases and traders weigh whether this is the momen...